documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
339 rows where docket_id = "FDA-1987-N-0054" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 4
- Other 175
- Supporting & Related Material 160
- Notice 3
- Rule 1
posted_year 1
- 2018 339
agency_id 1
- FDA 339
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1987-N-0054-0334 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Withdrawal Letter from Piper & Marbury to FDA DDM | Other | Withdrawal | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:43:14Z | 0 | 0 | 090000648046c812 | |||
| FDA-1987-N-0054-0335 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications | Notice | Withdrawal | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T05:00:00Z | 1997-06-26T03:59:59Z | 2018-02-26T14:44:26Z | 97-16602 | 0 | 0 | 090000648046c813 |
| FDA-1987-N-0054-0337 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications; Correction | Notice | Correction | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:46:44Z | 97-19012 | 0 | 0 | 090000648046c814 | ||
| FDA-1987-N-0054-0332 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service | Other | Certificate of Service | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:29:49Z | 0 | 0 | 090000648046c810 | |||
| FDA-1987-N-0054-0338 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Cover Letter from FDA DDM re Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications; Correction | Other | Letter(s) | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:47:06Z | 0 | 0 | 0900006482e64772 | |||
| FDA-1987-N-0054-0336 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Cover Letter from FDA DDM re Merck & Co., Inc., et al.; Withdrawal of Approval of 39 New Drug Applications, 13 Abbreviated Antibiotic Applications, and 46 Abbreviated New Drug Applications | Other | Withdrawal | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:45:13Z | 0 | 0 | 0900006482e57cf2 | |||
| FDA-1987-N-0054-0333 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Letter from Charles J. Raubicheck to FDA DDM | Other | Letter(s) | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:41:41Z | 0 | 0 | 090000648046c811 | |||
| FDA-1987-N-0054-0339 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Withdrawal for Request of Hearing from Watson Laboratories | Other | Withdrawal | 2018-02-26T05:00:00Z | 2018 | 2 | 2018-02-26T14:48:07Z | 0 | 0 | 090000648046c815 | |||
| FDA-1987-N-0054-0325 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Request for Exception from Bolar Pharmaceutical Company, Inc. (King and Spalding) | Other | Certificate of Service | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:09:53Z | 0 | 0 | 0900006482e54d4b | |||
| FDA-1987-N-0054-0319 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Request for Exception from Jones Medical Industries, Inc. (Kleinfeld, Kaplan & Becker) | Other | Exception/Waiver | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T14:39:03Z | 0 | 0 | 090000648046c809 | |||
| FDA-1987-N-0054-0323 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company’s Exceptions to Initial Decision July 10, 1989 (Vol. 3 of 3) | Supporting & Related Material | Background Material | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T14:58:23Z | 0 | 0 | 0900006482e4c1e9 | |||
| FDA-1987-N-0054-0329 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Center's Response to Warner -Lambert's Motion to Reopen the Administration Record and to Remand from FDA CDER | Other | Reply | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:31:32Z | 0 | 0 | 090000648046c80e | |||
| FDA-1987-N-0054-0328 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company's Motion to Reopen the Administrative Record and to Remand | Other | Motion | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:30:58Z | 0 | 0 | 090000648046c80d | |||
| FDA-1987-N-0054-0331 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Order Denying Warner -Lambert's Motion to Reopen The Administrative Record from FDA | Other | Order | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:33:22Z | 0 | 0 | 090000648046c80f | |||
| FDA-1987-N-0054-0322 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company’s Exceptions to Initial Decision July 10, 1989 (Vol. 2 of 3) | Supporting & Related Material | Background Material | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T14:57:56Z | 0 | 0 | 0900006482e29143 | |||
| FDA-1987-N-0054-0324 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Request for Exception from Bolar Pharmaceutical Company, Inc. (King and Spalding) | Other | Exception/Waiver | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:00:19Z | 0 | 0 | 090000648046c80b | |||
| FDA-1987-N-0054-0318 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Disclosure of Data and Information from Jones Medical Industries, Inc. | Other | Certificate of Service | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T14:34:36Z | 0 | 0 | 090000648046c808 | |||
| FDA-1987-N-0054-0327 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Warner- Lambert's Exceptions to the Initial Decision from FDA CDER | Other | Certificate of Service | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:12:08Z | 0 | 0 | 0900006482e54d4d | |||
| FDA-1987-N-0054-0330 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Center's Response to Warner -Lambert's Motion to Reopen the Administration Record and to Remand from FDA CDER | Other | Certificate of Service | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:31:52Z | 0 | 0 | 0900006482e54f3a | |||
| FDA-1987-N-0054-0326 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Response to Warner- Lambert's Exceptions to the Initial Decision from FDA CDER | Other | Reply | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T15:11:37Z | 0 | 0 | 090000648046c80c | |||
| FDA-1987-N-0054-0320 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Request for Exception from Jones Medical Industries, Inc. (Kleinfeld, Kaplan & Becker) | Other | Certificate of Service | 2018-02-23T05:00:00Z | 2018 | 2 | 2018-02-23T14:56:56Z | 0 | 0 | 0900006482e54738 | |||
| FDA-1987-N-0054-0321 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company’s Exceptions to Initial Decision July 10, 1989 (Vol. 1 of 3) | Other | Exception/Waiver | 2018-02-23T05:00:00Z | 2018 | 2 | 2020-01-31T06:55:32Z | 0 | 0 | 090000648046c80a | |||
| FDA-1987-N-0054-0317 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Letter from Warner-Lambert Company to Honorable Daniel J. Davidson | Other | Letter(s) | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T16:48:08Z | 0 | 0 | 090000648046c806 | |||
| FDA-1987-N-0054-0313 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Post-Hearing Brief of Bolar Pharmaceutical Company, Inc. | Other | Brief | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T16:08:49Z | 0 | 0 | 090000648046c802 | |||
| FDA-1987-N-0054-0303 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Exhibits G-201, G-202, G-244 thru G-247 re: Parties' Master Evidence List from FDA | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T13:37:54Z | 0 | 0 | 0900006482e31295 | |||
| FDA-1987-N-0054-0302 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Parties' Master Evidence List from FDA CDER | Other | Certificate of Service | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T13:35:59Z | 0 | 0 | 0900006482e30586 | |||
| FDA-1987-N-0054-0301 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Index re: Parties' Master Evidence List from FDA CDER | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T13:35:15Z | 0 | 0 | 0900006482e54d86 | |||
| FDA-1987-N-0054-0315 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Brief of Jones Medical Industries, Inc. and Inwood Laboratories, Inc. | Other | Brief | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T16:12:08Z | 0 | 0 | 090000648046c803 | |||
| FDA-1987-N-0054-0314 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Post-Hearing Brief of Bolar Pharmaceutical Company, Inc. | Other | Certificate of Service | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T16:09:15Z | 0 | 0 | 0900006482e305f9 | |||
| FDA-1987-N-0054-0308 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Exhibits B-001 through B-003B re: Parties' Master Evidence List from FDA CDER | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:46:41Z | 0 | 0 | 0900006482e4bebd | |||
| FDA-1987-N-0054-0316 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Brief of Jones Medical Industries, Inc. and Inwood Laboratories, Inc. | Other | Certificate of Service | 2018-02-21T05:00:00Z | 2018 | 2 | 2020-01-31T06:56:04Z | 0 | 0 | 0900006482e2fcbd | |||
| FDA-1987-N-0054-0307 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Index of Exhibits B-001 thru B-003B re: Parties' Master Evidence List from FDA CDER | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:46:27Z | 0 | 0 | 0900006482e5599a | |||
| FDA-1987-N-0054-0304 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Exhibits G-256 thru G-281 re: Parties' Master Evidence List from FDA | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:37:44Z | 0 | 0 | 0900006482e2fcbf | |||
| FDA-1987-N-0054-0305 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Exhibits G-249 thru G-255A. re: Parties' Master Evidence List from FDA | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:38:52Z | 0 | 0 | 0900006482e30a3f | |||
| FDA-1987-N-0054-0300 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Parties' Master Evidence List from FDA CDER | Other | List (LST) | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T13:34:29Z | 0 | 0 | 090000648046c7ff | |||
| FDA-1987-N-0054-0310 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Table of Contents for Exhibits W-1 thru W-101 re: Parties' Master Evidence List from FDA CDER | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:47:47Z | 0 | 0 | 0900006482e54e8b | |||
| FDA-1987-N-0054-0312 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company's Post-Hearing Brief | Other | Brief | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:49:32Z | 0 | 0 | 090000648046c801 | |||
| FDA-1987-N-0054-0311 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Brief for the Center for Drug Evaluation and Research | Other | Brief | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:48:54Z | 0 | 0 | 090000648046c800 | |||
| FDA-1987-N-0054-0309 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Index of Exhibits W-1 thru W-123 re: Parties' Master Evidence List from FDA CDER | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:47:35Z | 0 | 0 | 0900006482e54d81 | |||
| FDA-1987-N-0054-0306 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Exhibits G-282 thru G-298. re: Parties' Master Evidence List from FDA | Supporting & Related Material | Background Material | 2018-02-21T05:00:00Z | 2018 | 2 | 2018-02-21T15:46:04Z | 0 | 0 | 0900006482e300da | |||
| FDA-1987-N-0054-0299 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service from Lyle D. Jaffe | Other | Certificate of Service | 2018-02-20T05:00:00Z | 2018 | 2 | 2018-02-20T13:55:11Z | 0 | 0 | 090000648046c7fe | |||
| FDA-1987-N-0054-0296 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company's Motion for Enlargement of Time in Which to File Briefs | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:42:48Z | 0 | 0 | 090000648046c7fc | |||
| FDA-1987-N-0054-0277 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Center's Response to Warner-Lambert's Motion to Readmit Strickened Evidence | Other | Response(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:33:36Z | 0 | 0 | 090000648046c7f1 | |||
| FDA-1987-N-0054-0298 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Motion to Strike Participation of Armour Pharmaceutical CO. from FDA CDER | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T05:00:00Z | 2018-02-16T16:45:20Z | 0 | 0 | 090000648046c7a7 | ||
| FDA-1987-N-0054-0295 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service from Lyle D. Jaffe | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:42:15Z | 0 | 0 | 090000648046c7fb | |||
| FDA-1987-N-0054-0292 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lamber Company's Opposition to Center's Application to Renew Motion to Strike | Other | Reply | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:40:53Z | 0 | 0 | 090000648046c7f9 | |||
| FDA-1987-N-0054-0284 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Letter from Warner-Lambert Company (Davis Hoxie Faithfull & Hapgood) | Other | Letter(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:37:20Z | 0 | 0 | 090000648046c7f5 | |||
| FDA-1987-N-0054-0281 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Warner-Lambert Company's Motion to Add a Witness and to Readmit Evidence into the Evidentiary Record | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:35:42Z | 0 | 0 | 0900006482e2f8cc | |||
| FDA-1987-N-0054-0287 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Application to Renew Motion to Strike from FDA CDER | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:38:37Z | 0 | 0 | 0900006482e2ef03 | |||
| FDA-1987-N-0054-0285 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Letter from Warner-Lambert Company (Davis Hoxie Faithfull & Hapgood) | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:37:42Z | 0 | 0 | 0900006482e2eea2 | |||
| FDA-1987-N-0054-0268 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Motion for Leave to Ask Questions on Oral Direct Examination from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:04:38Z | 0 | 0 | 0900006482e52f0c | |||
| FDA-1987-N-0054-0266 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:03:37Z | 0 | 0 | 090000648046c7eb | |||
| FDA-1987-N-0054-0282 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Response to Warner-lambert Company's Motion to Add a Witness and to Readmit Evidence into the Evidentiary Record | Other | Reply | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:36:17Z | 0 | 0 | 090000648046c7f4 | |||
| FDA-1987-N-0054-0290 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Center's Response to Warner-Lambert Company's Motion to Readmit Evidence | Other | Reply | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:39:59Z | 0 | 0 | 090000648046c7f8 | |||
| FDA-1987-N-0054-0283 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Warner-lambert Company's Motion to Add a Witness and to Readmit Evidence into the Evidentiary Record | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:36:35Z | 0 | 0 | 0900006482e2e3d9 | |||
| FDA-1987-N-0054-0286 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Application to Renew Motion to Strike from FDA CDER | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:38:18Z | 0 | 0 | 090000648046c7f6 | |||
| FDA-1987-N-0054-0279 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Questions for Warner-Lambert Company's Oral Direct Testimony (Davis, Hoxie, et al) | Other | Letter(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:34:47Z | 0 | 0 | 090000648046c7f2 | |||
| FDA-1987-N-0054-0272 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Application for Limited Additional Oral Direct Testimony from FDA CDER | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:56:37Z | 0 | 0 | 0900006482e53003 | |||
| FDA-1987-N-0054-0288 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company's Motion to Readmit Evidence | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:39:08Z | 0 | 0 | 090000648046c7f7 | |||
| FDA-1987-N-0054-0294 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Order in the Matter of Pentaerythritol Tetranitrate: Proposal to Withdraw Approval of Certain New Drug Applications | Other | Order | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:41:47Z | 0 | 0 | 090000648046c7fa | |||
| FDA-1987-N-0054-0291 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Center's Response to Warner-Lambert Company's Motion to Readmit Evidence | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:40:21Z | 0 | 0 | 0900006482e301e5 | |||
| FDA-1987-N-0054-0289 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Warner-Lambert Company's Motion to Readmit Evidence | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:39:26Z | 0 | 0 | 0900006482e2ef57 | |||
| FDA-1987-N-0054-0267 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Response to Motion for Leave to Ask Questions on Oral Direct Examination from Warner- Lambert Company (Davis, Hoxie, et al) | Other | Response(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:04:21Z | 0 | 0 | 090000648046c7ec | |||
| FDA-1987-N-0054-0276 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Errata Notice Correcting Schedule for Cross -Examination of Dr. Leung from FDA CDER | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:33:00Z | 0 | 0 | 0900006482e530c3 | |||
| FDA-1987-N-0054-0269 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Motion to Readmit Evidence Stricken from Evidentiary Record from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:55:01Z | 0 | 0 | 090000648046c7ed | |||
| FDA-1987-N-0054-0278 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Motion to Readmit Strickened Evidence from FDA CDER | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:33:56Z | 0 | 0 | 0900006482e53970 | |||
| FDA-1987-N-0054-0273 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Amended Schedule for Cross- Examination from FDA CDER | Other | Letter(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:57:47Z | 0 | 0 | 090000648046c7ef | |||
| FDA-1987-N-0054-0270 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Motion to Readmit Evidence Stricken from Evidentiary Record from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:55:18Z | 0 | 0 | 0900006482e52f10 | |||
| FDA-1987-N-0054-0274 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Amended Schedule for Cross- Examination from FDA CDER | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:59:11Z | 0 | 0 | 0900006482e53526 | |||
| FDA-1987-N-0054-0275 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Errata Notice Correcting Schedule for Cross- Examination of Dr. Leung from FDA CDER | Other | Correction(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:32:43Z | 0 | 0 | 090000648046c7f0 | |||
| FDA-1987-N-0054-0271 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Response to Application for Limited Additional Oral Direct Testimony from FDA CDER | Other | Response(s) | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T14:56:20Z | 0 | 0 | 090000648046c7ee | |||
| FDA-1987-N-0054-0280 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Warner-Lambert Company's Motion to Add a Witness and to Readmit Evidence into the Evidentiary Record | Other | Motion | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:35:25Z | 0 | 0 | 090000648046c7f3 | |||
| FDA-1987-N-0054-0297 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Warner-Lambert Company's Motion for Enlargement of Time in Which to File Briefs | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:43:04Z | 0 | 0 | 0900006482e30063 | |||
| FDA-1987-N-0054-0293 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Warner-Lamber Company's Opposition to Center's Application to Renew Motion to Strike | Other | Certificate of Service | 2018-02-16T05:00:00Z | 2018 | 2 | 2018-02-16T16:41:15Z | 0 | 0 | 0900006482e2fea3 | |||
| FDA-1987-N-0054-0238 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Notice of Witnesses to Be Cross -Examined from Bolar Pharmaceutical Company, Inc. | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:42:55Z | 0 | 0 | 0900006482e4d135 | |||
| FDA-1987-N-0054-0240 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Notice of Withdrawal of Direct Testimony from FDA CDER | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:44:19Z | 0 | 0 | 0900006482e4d1d9 | |||
| FDA-1987-N-0054-0233 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Notice of Cross-Examination of Hearing Witnesses from Warner-Lambert Company (Davis, Hoxie, et al.) | Other | List (LST) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:35:59Z | 0 | 0 | 090000648046c7d7 | |||
| FDA-1987-N-0054-0248 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Uncontested Motion for Enlargement of Time from Warner- Lambert Company (Stovall and Spradlin) | Other | Motion | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:02:18Z | 0 | 0 | 090000648046c7e0 | |||
| FDA-1987-N-0054-0257 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Motion for Leave to Ask Questions on Oral Direct Examination from FDA | Other | Motion | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:14:41Z | 0 | 0 | 090000648046c7e6 | |||
| FDA-1987-N-0054-0262 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Amended Schedule of Cross -Examination of Hearing Witnesses from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:50:38Z | 0 | 0 | 0900006482e502f8 | |||
| FDA-1987-N-0054-0247 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Motion for Certification of Interlocutory Appeal from Warner-Lambert Company | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:49:54Z | 0 | 0 | 0900006482e4d36b | |||
| FDA-1987-N-0054-0234 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Notice of Cross- Examination of Hearing Witnesses from Warner- Lambert Company (Davis, Hoxie, et al.) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:36:15Z | 0 | 0 | 0900006482e4c8b1 | |||
| FDA-1987-N-0054-0246 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Motion for Certification of Interlocutory Appeal from Warner-Lambert Company | Other | Motion | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:49:31Z | 0 | 0 | 090000648046c7df | |||
| FDA-1987-N-0054-0263 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Correction of Typographical Error in Stipulated Amendment from Warner -Lambert Company (Stovall & Spradlin) | Other | Correction(s) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:51:26Z | 0 | 0 | 090000648046c7e9 | |||
| FDA-1987-N-0054-0250 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Correction of Typographical & Collation Errors from Warner-Lambert Company (Stovall & Spradlin) | Other | Correction(s) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:03:49Z | 0 | 0 | 090000648046c7e1 | |||
| FDA-1987-N-0054-0232 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Tab #48 | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T13:42:14Z | 0 | 0 | 090000648046c7d6 | |||
| FDA-1987-N-0054-0258 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Motion for Leave to Ask Questions on Oral Direct Examination from FDA | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:15:28Z | 0 | 0 | 0900006482e4ff6d | |||
| FDA-1987-N-0054-0264 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Correction of Typographical Error in Stipulated Amendment from Warner- Lambert Company (Stovall & Spradlin) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:51:44Z | 0 | 0 | 0900006482e5063c | |||
| FDA-1987-N-0054-0236 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Notice of Witnesses to Be Cross -Examined from Inwood Labs Inc et al (Kleinfeld, Kaplan and Becker) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:40:33Z | 0 | 0 | 0900006482e4cd71 | |||
| FDA-1987-N-0054-0245 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:48:36Z | 0 | 0 | 090000648046c7de | |||
| FDA-1987-N-0054-0252 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:06:23Z | 0 | 0 | 090000648046c7e3 | |||
| FDA-1987-N-0054-0235 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Notice of Witnesses to be Cross- Examined from Inwood Labs Inc et al (Kleinfeld, Kaplan and Becker) | Other | List (LST) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:39:51Z | 0 | 0 | 090000648046c7d8 | |||
| FDA-1987-N-0054-0237 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Notice of Witnesses to Be Cross-Examined from Bolar Pharmaceutical Company, Inc. | Other | List (LST) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:42:34Z | 0 | 0 | 090000648046c7d9 | |||
| FDA-1987-N-0054-0241 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Opposition to Notice of Withdrawal of Direct Testimony & Motion for Enforcement of Prior Order from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Motion | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:45:40Z | 0 | 0 | 090000648046c7db | |||
| FDA-1987-N-0054-0259 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Application for Limited Additional Oral Direct Testimony from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Motion | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:16:26Z | 0 | 0 | 090000648046c7e7 | |||
| FDA-1987-N-0054-0249 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Uncontested Motion for Enlargement of Time from Warner- Lambert Company (Stovall and Spradlin) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:02:43Z | 0 | 0 | 0900006482e4e889 | |||
| FDA-1987-N-0054-0261 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Amended Schedule of Cross- Examination of Hearing Witnesses from Warner -Lambert Company (Davis, Hoxie, et al) | Other | Letter(s) | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:50:23Z | 0 | 0 | 090000648046c7e8 | |||
| FDA-1987-N-0054-0242 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Opposition to Notice of Withdrawal of Direct Testimony & Motion for Enforcement of Prior Order from Warner-Lambert Company (Davis, Hoxie, et al) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T14:45:58Z | 0 | 0 | 0900006482e4d916 | |||
| FDA-1987-N-0054-0256 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Response to Motion for Certification of Interlocutory Appeal from FDA | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:11:05Z | 0 | 0 | 0900006482e4f6de | |||
| FDA-1987-N-0054-0260 | FDA | Pentaerythritol Tetranitrate (PETN) - Open FDA-1987-N-0054 | Certificate of Service re: Application for Limited Additional Oral Direct Testimony from Warner- Lambert Company (Davis, Hoxie, et al) | Other | Certificate of Service | 2018-02-15T05:00:00Z | 2018 | 2 | 2018-02-15T15:16:53Z | 0 | 0 | 0900006482e4ff73 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);